Dr. Graze is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
810 Bestgate Road
Suite 400
Annapolis, MD 21401Phone+1 410-897-6200Fax+1 410-266-7636
Summary
- I am a board certified hematologist-oncologist with more than 40 years clinical practice and clinical research experience. My current special interests include thoracic oncology, neuro-oncology, head and neck cancers, and palliative care
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1975 - 1977
Massachusetts General HospitalResidency, Internal Medicine, 1971 - 1973
Harvard Medical SchoolClass of 1971
Certifications & Licensure
MD State Medical License 1974 - 2026
NV State Medical License 1979 - 2005
CA State Medical License 1975 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
Publications & Presentations
PubMed
- 53 citationsPharmacovigilance and biosimilars: considerations, needs and challengesNicole Casadevall, I. Ralph Edwards, Thomas Felix, Peter R Graze, Jason B. Litten
Expert Opinion on Biological Therapy. 2013-06-07 - 156 citationsRandomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–S...Charles A. Butts, David Bodkin, Edward L. Middleman, Craig W. Englund, David W. Ellison
Journal of Clinical Oncology. 2007-12-20 - 48 citationsHigh-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancerDan Douer, Richard E. Champlin, Winston G. Ho, Gregory Sarna, John H. Wells
The American Journal of Medicine. 1981-12-01
Committees
- Member, AAMC thoracic oncology steering committee 2012 - 2020
Professional Memberships
- Member
- Member
Other Languages
- French
External Links
- Maryland Oncology Hematologyhttp://marylandoncology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
